
Mylan Defeats Sanofi’s EpiPen Antitrust Suit
Mylan has dodged claims that it unlawfully shielded its EpiPen from competition by driving Sanofi’s epinephrine auto-injector from the market through exclusive

Mylan has dodged claims that it unlawfully shielded its EpiPen from competition by driving Sanofi’s epinephrine auto-injector from the market through exclusive

Uber announced Tuesday, February 2, that it is acquiring alcohol-delivery service Drizly for US$1.1 billion in stock and cash, reported CNBC.

ByteDance’s Chinese short video app Douyin has filed a complaint with a court in Beijing to sue Tencent Holdings for

Five gamers filed an antitrust class action law suit accusing Valve of forcing developers to list the same prices for

US legal group Simpson Thacher is opening an EU office in a sign of the disruption Brexit may cause corporate

EU antitrust regulators will decide by March 5 whether to clear Microsoft’s US$7.5 billion acquisition of ZeniMax Media, the US

Compass Lexecon has announced that it is opening an office in Milan, Italy. Compass Lexecon’s 280-strong team in Europe, the

Van Bael & Bellis has announced the promotion of EU law specialist Aldo Scalini to Counsel. Scalini joined Van Bael

By Pauline Affeldt & Tomaso Duso (German Institute for Economic Research), Klaus Gugler (Vienna University), Joanna Piechucka (Paris School of

The Supreme Court on Monday, February 1, released the calendar for its March argument session, scheduling arguments on issues including student-athlete compensation.
© Competition Policy International 2024